Literature DB >> 9684147

Ductal adenocarcinoma of the pancreas head: survival after regional versus extended lymphadenectomy.

D Henne-Bruns1, I Vogel, J Lüttges, G Klöppel, B Kremer.   

Abstract

BACKGROUNDS/AIMS: The aim of the study was to evaluate the influence of regional versus extended lymphadenectomy on survival in patients with ductal adenocarcinoma of the head of the pancreas. From 1988 to 1996 we performed partial duodeno-pancreatectomies (Whipple procedure) combined with either regional (n = 20, group A) or extended retroperitoneal (n = 33, group B) lymphadenectomy in 53 patients with ductal adenocarcinoma of the pancreas head.
METHODOLOGY: The outcome of the two groups was compared by constructing survival curves and evaluating demographic, intraoperative and histopathologic data from all patients (n = 44) with curative (R0) resections.
RESULTS: For patients after R0 resection there was no significant difference in terms of survival between group A and B. Only tumor stage (p = 0.0258), portal vein invasion (p = 0.0190) and tumor grade (p = 0.0021) had a significant influence on survival, regardless of the type of operation.
CONCLUSION: Our data suggest that no further improvement of the survival rate can be achieved by extended retroperitoneal lymphadenectomy, compared to regional lymphadenectomy.

Entities:  

Mesh:

Year:  1998        PMID: 9684147

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  24 in total

1.  Extended pancreatic resections and lymphadenectomy: An appraisal of the current evidence.

Authors:  Shailesh V Shrikhande; Savio G Barreto
Journal:  World J Gastrointest Surg       Date:  2010-02-27

Review 2.  The lymphatic system and pancreatic cancer.

Authors:  Darci M Fink; Maria M Steele; Michael A Hollingsworth
Journal:  Cancer Lett       Date:  2015-12-29       Impact factor: 8.679

3.  Pancreatic resection for pancreatic cancer.

Authors:  Jeannine Bachmann; Christoph W Michalski; Marc E Martignoni; Markus W Büchler; Helmut Friess
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

Review 4.  Meta-analysis of the efficacies of extended and standard pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas.

Authors:  Jingfeng Sun; Yinxue Yang; Xuan Wang; Zhen Yu; Ting Zhang; Jun Song; Hewei Zhao; Jianfei Wen; Yong Du; Wan Yee Lau; Yewei Zhang
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

5.  Significant growth inhibition of orthotopic pancreatic ductal adenocarcinoma by CpG oligonucleotides in immunodeficient mice.

Authors:  J Tepel; O Dagvadorj; M Kapischke; B Sipos; A Leins; B Kremer; H Kalthoff
Journal:  Int J Colorectal Dis       Date:  2005-08-16       Impact factor: 2.571

6.  Pancreatic adenocarcinoma: complete tumor extirpation improves survival benefit despite larger tumors for patients who undergo distal pancreatectomy and splenectomy.

Authors:  Paul Toomey; Jonathan Hernandez; Farhaad Golkar; Sharona Ross; Kenneth Luberice; Alexander Rosemurgy
Journal:  J Gastrointest Surg       Date:  2011-12-02       Impact factor: 3.452

7.  Detection of micrometastases in peritoneal washings of pancreatic cancer patients by the reverse transcriptase polymerase chain reaction.

Authors:  Kimberly Moore Dalal; Yanghee Woo; Charles Galanis; Mithat Gonen; Laura Tang; Peter Allen; Ronald DeMatteo; Yuman Fong; Daniel G Coit
Journal:  J Gastrointest Surg       Date:  2007-09-19       Impact factor: 3.452

Review 8.  [Indications for surgical resection of benign pancreatic tumors].

Authors:  R Isenmann; D Henne-Bruns
Journal:  Radiologe       Date:  2008-08       Impact factor: 0.635

9.  Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma.

Authors:  Tomar Ghansah; Nasreen Vohra; Kathleen Kinney; Amy Weber; Krithika Kodumudi; Gregory Springett; Amod A Sarnaik; Shari Pilon-Thomas
Journal:  Cancer Immunol Immunother       Date:  2013-04-19       Impact factor: 6.968

10.  Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors.

Authors:  Tom C Nguyen; Taylor A Sohn; John L Cameron; Keith D Lillemoe; Kurtis A Campbell; JoAnn Coleman; Patricia K Sauter; Ross A Abrams; Ralph H Hruban; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2003-01       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.